Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) received Fast Track Designation from the U.S. Food and Drug Administration for its ifetroban therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE